MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas

With more than 80% of all diagnosed lung cancer cases, non-small cell lung cancer (NSCLC) remains the leading cause of cancer death worldwide. Exact diagnosis is mostly very late and advanced-stage NSCLCs are inoperable at admission. Tailored therapies with tyrosine kinase inhibitors are only availa...

Descripción completa

Detalles Bibliográficos
Autores principales: Fadejeva, Irina, Olschewski, Horst, Hrzenjak, Andelko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777811/
https://www.ncbi.nlm.nih.gov/pubmed/29383199
http://dx.doi.org/10.18632/oncotarget.22975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777811/
https://www.ncbi.nlm.nih.gov/pubmed/29383199
http://dx.doi.org/10.18632/oncotarget.22975

Ejemplares similares